Armune BioScience Secures $5,552,032 New Funding

  • Feed Type
  • Date
    2/19/2016
  • Company Name
    Armune BioScience
  • Mailing Address
    350 East Michigan Ave. Kalamazoo, MI 49007 USA
  • Company Description
    Armune BioScience, Inc. will develop and commercialize molecular diagnostic and prognostic tests for prostate, lung and breast cancers that will allow physicians and patients to make more personalized treatment decisions.
  • Website
    http://www.armune.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $5,552,032
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy